Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Schönfeld, Mirjam ^a   Barreto Miranda, Isabel ^a   Schunk, Mirjam ^a   Maduhu, Ibrahim ^b   Maboko, Leonard ^c   Hoelscher, Michael ^a,c   Berens Riha, Nicole ^a   Kitua, Andrew ^d   Löscher, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Mbeya Referral Hospital Tanzania   (Tanzania)

^c Mbeya Medical Research Programme (MMRP)   (Tanzania)

^d NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; MOLECULAR MARKER;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG TREATMENT FAILURE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MUTATIONAL ANALYSIS; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PREDICTION; SAMPLE SIZE; TANZANIA;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POINT MUTATION; PYRIMETHAMINE; SULFADOXINE; TANZANIA; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 33846545030     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-2     Document Type: Article

References (32)

1. WHO, World Malaria Report 2005. Geneva 2005
2. WHO, Global Health Atlas. Geneva 2005
3. Ministry of Health Tanzania, Malaria Treatment Guidelines. Dar es Salam 2000
4. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. T Mutabingwa A Nzila E Mberu E Nduati P Winstanley E Hills W Watkins, Lancet 2001 358 1218 1223 10.1016/S0140-6736(01)06344-9 11675058
5. Modern chemotherapeutic options for malaria. P Winstanley, Lancet Infect Dis 2001 1 242 250 10.1016/S1473-3099(01)00119-0 11871511
6. A molecular marker for chloroquine-resistant falciparum malaria. A Djimde OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourte A Dicko XZ Su T Nomura DA Fidock TE Wellems CV Plowe D Coulibaly, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
7. Drug resistance in Plasmodium falciparum malaria. DC Warhurst, Infection 1999 27 Suppl 2 S55 58 10885831
8. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. DA Fidock T Nomura AK Talley RA Cooper SM Dzekunov MT Ferdig LM Ursos AB Sidhu B Naude KW Deitsch XZ Su JC Wootton PD Roepe TE Wellems, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
9. Biochemical and molecular mechanisms of drug resistance in parasites. M Ouellette, Trop Med Int Health 2001 6 874 882 10.1046/j.1365-3156.2001.00777.x 11703841
10. Chloroquine-resistant malaria. TE Wellems CV Plowe, J Infect Dis 2001 184 770 776 10.1086/322858 11517439
11. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Stromberg A Martensson M Msellem C Obondo A Bjorkman JP Gil, J Infect Dis 2005 191 6 1014 1017 10.1086/427997 15717281
12. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. MT Duraisingh P Jones I Sambou L von Seidlein M Pinder DC Warhurst, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315
13. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. DJ Bzik WB Li T Horii J Inselburg, Proc Natl Acad Sci USA 1987 84 8360 8364 2825189 10.1073/pnas.84.23. 8360
14. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. DR Brooks P Wang M Read WM Watkins PF Sims JE Hyde, Eur J Biochem 1994 224 397 405 10.1111/j.1432-1033. 1994.00397.x 7925353
15. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. JG Kublin FK Dzinjalamala DD Kamwendo EM Malkin JF Cortese LM Martino RA Mukadam SJ Rogerson AG Lescano ME Molyneux PA Winstanley P Chimpeni TE Taylor CV Plowe, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
16. Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. CT Happi GO Gbotosho OA Folarin OM Bolaji A Sowunmi DE Kyle W Milhous DF Wirth AM Oduola, Am J Trop Med Hyg 2006 75 155 161 16837724
17. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. B Schwobel M Alifrangis A Salanti T Jelinek, Malar J 2003 2 5 12665429 10.1186/1475-2875-2-5
18. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. L Musset O Bouchaud S Matheron L Massias J Le Bras, Microbes Infect 2006
19. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. O Wichmann N Muehlberger T Jelinek M Alifrangis G Peyerl-Hoffmann M Muhlen MP Grobusch J Gascon A Matteelli H Laferl Z Bisoffi S Ehrhardt J Cuadros C Hatz I Gjorup P McWhinney J Beran S da Cunha M Schulze H Kollaritsch P Kern G Fry J Richter European Network on Surveillance of Imported Infectious Diseases, J Infect Dis 2004 190 1541 1546 10.1086/424469 15478057
20. Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. KC Kain DE Lanar, J Clin Microbiol 1991 29 1171 1174 1864936
21. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. G Snounou S Viriyakosol XP Zhu W Jarra L Pinheiro VE do Rosario S Thaithong KN Brown, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
22. Plasmodium falciparum : detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. MT Duraisingh J Curtis DC Warhurst, Exp Parasitol 1998 89 1 8 10.1006/expr.1998.4274 9603482
23. Correlation of in vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda. TP Flueck T Jelinek AH Kilian IS Adagu G Kabagambe F Sonnenburg DC Warhurst, Trop Med Int Health 2000 5 174 178 10.1046/j.1365-3156.2000.00543.x 10747279
24. Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb). JP Gil F Nogueira J Stromberg-Norklit J Lindberg M Carrolo C Casimiro D Lopes AP Arez PV Cravo VE Rosario, Mol Cell Probes 2003 17 85 89 10.1016/S0890-8508(03)00006-9 12788029
25. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. K Mugittu M Ndejembi A Malisa M Lemnge Z Premji A Mwita W Nkya J Kataraihya S Abdulla HP Beck H Mshinda, Am J Trop Med Hyg 2004 71 696 702 15642957
26. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. K Mugittu S Abdulla N Falk H Masanja I Felger H Mshinda HP Beck B Genton, Malar J 2005 4 55 16297234 10.1186/1475-2875-4-55
27. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. JG Kublin JF Cortese EM Njunju RA Mukadam JJ Wirima PN Kazembe AA Djimde B Kouriba TE Taylor CV Plowe, J Infect Dis 2003 187 1870 1875 10.1086/375419 12792863
28. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. T Mita A Kaneko JK Lum B Bwijo M Takechi IL Zungu T Tsukahara K Tanabe T Kobayakawa A Bjorkman, Am J Trop Med Hyg 2003 68 413 415 12875289
29. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. AB Sidhu AC Uhlemann SG Valderramos JC Valderramos S Krishna DA Fidock, J Infect Dis 2006 194 528 535 10.1086/507115 16845638
30. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. B Bwijo A Kaneko M Takechi IL Zungu Y Moriyama JK Lum T Tsukahara T Mita N Takahashi Y Bergqvist A Bjorkman T Kobayakawa, Acta Trop 2003 85 363 373 10.1016/S0001-706X(02)00264-4 12659974
31. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum : genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. AM Nzila EK Mberu J Sulo H Dayo PA Winstanley CH Sibley WM Watkins, Antimicrob Agents Chemother 2000 44 991 996 10722502 10.1128/AAC.44.4.991-996.2000
32. Molecular surveillance of mutations in dihydrofolate reductase and dihyropteroate synthase genes of Plasmodium falciparum in Ethiopia. T Gebru-Woldearegai A Hailu MP Grobusch JF Kun, Am J Trop Med Hyg 2005 73 1131 1134 16354825